Intercept Pharmaceuticals (Nasdaq: ICPT) stock surged 45% today (Tuesday) to a new 52-week high of $349.08 after the company reported Q2 results and provided promising updates on several of its key drugs.
- Intercept Pharma (Nasdaq: ICPT) Stock Skyrockets 45% on Liver Disease Treatment
- Stocks to Buy: Intercept Pharma (Nasdaq: ICPT) Ready to Double
- U.S. Stock Market News Today: Check Out the Pharma Stock That Soared 300%
Usually the best stocks to buy have not already tripled in value within the past six months.
But then there's Intercept Pharmaceuticals Inc. (Nasdaq: ICPT).
This biotech stock soared more than 500% in two days on the news its innovative and promising hepatitis drug obeticholic acid, or OCA, had a trial stopped early because the drug met the goals of the study.
Bulls have refused to be distracted by some negative news that has pushed the stock back under $300 in the meantime.
Stock Market News Today, Jan. 9, 2014: U.S. stocks are fairly flat today, with all three indexes down just a smidge, weighed after today's jobless claims report that was on par with analyst expectations.